| 英文别名 |
Conivaptan hydrochloride;N-[4-(2-Methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride;Conivaptan HCl;Conivaptan hydrochkoride;YM 087;(1,1'-Biphenyl)-2-carboxamide,N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-,monohydrochloride;CI-1025;Conivaptan hydrochloride [USAN];UNII-75L57R6X36;Vaprisol;YM-087;N-[4-[(4,5-dihydro-2methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]- [1,1’-biphenyl]-2-carboxamide monohydrochloride;Conivaptan HCI;N-[4-(2-Methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamid;Conivaptan hydrochloride, >=99%;Conivaptan (hydrochloride);Conivaptan HCl (Vaprisol);75L57R6X36;AK104672;4'-((4,5-Dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide monohydrochloride;C32H27ClN4O2;(1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihyd;AM20090724;CHEMBL1201108;CONIVAPTAN HYDROCHLORIDE [MI];(1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride;MFCD00945712;DTXCID9091076;N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-Biphenyl]-2-carboxamide Hydrochloride;CONIVAPTAN HYDROCHLORIDE [ORANGE BOOK];N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamidehydrochloride;VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER;Vaprisol (TN);N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride;MLS006010233;AKOS025401635;CONIVAPTAN HCL [VANDF];4''-((4,5-DIHYDRO-2-METHYLIMIDAZO(4,5-D)(1)BENZAZEPIN-6(1H)-YL)CARBONYL)-2-BIPHENYLCARBOXANILIDE MONOHYDROCHLORIDE;CONIVAPTAN HYDROCHLORIDE (MART.);SMR004701209;Vaprisol, Conivaptan hydrochloride;CCG-269940;4'-[(2-Methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide monohydrochloride;8626-94-6;SW219215-1;CONIVAPTAN HYDROCHLORIDE [MART.];BCP28426;4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide hydrochloride;Conivaptan hydrochloride (JAN/USAN);CHEBI:31430;Q27114306;EX-A1128;N-(4-((2-methyl-4,5-dihydroimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)biphenyl-2-carboxamide hydrochloride;AC-23918;BTYHAFSDANBVMJ-UHFFFAOYSA-N;CS-2015;N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide Hydrochloride (1:1); [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride (9CI); Conivaptan hydrochloride; Vaprisol; YM 087; conivaptan monohydrochloride;FT-0657174;D01236;DTXSID70168585;N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride;N-[4-({4-methyl-3,5,9-... |